Blog

Patent owner improperly dinged by Federal Circuit for correctly following Orange Book listing rules.

December 18, 2023

Federal Circuit rules that Argentum cannot pursue its appeal of a PTAB decision declining to institute an inter-partes review, even though Argentum might be estopped to challenge the patent in subsequent Hatch Waxman litigation

April 27, 2020

Patent claiming dose reduction for poor metabolizers affirmed at Federal Circuit.

April 22, 2018

Court finds Meda Pharmaceuticals’ delay asserting certificate of correction precludes adding the corrected claim to the lawsuit.

June 20, 2017